Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-Invasive Detection of Aspergillosis in Ventilated Patients: Galactomannan Analysis in Exhaled Breath

NCT06333379 is registered in ClinicalTrials.gov with Lin Chen as lead sponsor.

NCT NCT06333379
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06333379 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-Invasive Detection of Aspergillosis in Ventilated Patients: Galactomannan Analysis in Exhaled Breath
Lead sponsor
Lin Chen
Phase
Observational
Overall status
Completed
Start date
January 2, 2023
Completion date
January 10, 2024
Enrollment
75 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aspergillosis, invasive pulmonary, bronchoalveolar lavage fluid, critical illness, exhaled breath condensate, respiration failure, respiratory fungal infection, sensitivity and specificity